213
Participants
Start Date
June 21, 2017
Primary Completion Date
August 30, 2019
Study Completion Date
August 30, 2019
cobitolimod
Rectal administration
Placebo
Solution manufactured to mimic cobitolimod
1, Prague
2, Amiens
3, Caen
4, Clichy
5, Grenoble
6, Nice
7, Pierre-Bénite
8, Saint-Etienne
9, Toulouse
10, Vandœuvre-lès-Nancy
11, Augsburg
12, Berlin
13, Erlangen
14, Hamburg
15, Hanover
16, Heidelberg
17, Leipzig
18, Lüneburg
19, Mannheim
20, München
22, Békéscsaba
21, Budapest
23, Debrecen
24, Mosonmagyaróvár
25, Pécs
26, Częstochowa
27, Krakow
28, Ksawerów
33, Lodz
29, Lublin
30, Poznan
31, Sopot
32, Warsaw
33, Wroclaw
32, Włocławek
34, Cheboksary
36, Kazan'
37, Kirov
38, Moscow
39, Novosibirsk
40, Ryazan
41, Saint Petersburg
42, Stavropol
43, Tver'
44, Ufa
35, Yekaterinburg
45, Belgrade
46, Ferrol
47, Fuenlabrada
48, Madrid
49, Seville
50, Valencia
51, Uppsala
52, Chernivtsi
53, Dnipro
54, Ivano-Frankivsk
55, Kharkiv
56, Kiev
57, Lutsk
58, Lviv
59, Odesa
60, Sumy
62, Uzhhorod
61, Zaporizhzhya
Lead Sponsor
InDex Pharmaceuticals
INDUSTRY